Objective
Despite a great progress in the management of epilepsy, still one third of patients is refractory to available medications. The incidence of epilepsy is highest in infancy and 50% of children experience epilepsy-related comorbidities, such as developmental delay and autism. The development of epilepsy (epileptogenesis), extensively studied in animals, is barely studied in humans, as patients usually present AFTER the seizure onset.
EPISTOP is the first prospective study of epileptogenesis in humans, beginning BEFORE seizures and continuing through age 2+ years, permitting detailed analysis of the onset, drug-resistance, and comorbidities of epilepsy. To maximize information derived from the study we have chosen homogenous group of patients with prenatal or early infantile diagnosis of Tuberous Sclerosis Complex (TSC). A clinical randomized study of pre-seizure treatment in TSC infants is a part of the project.
The aim of EPISTOP is to examine the risk factors and biomarkers of epilepsy and to identify possible new therapeutic targets to block or otherwise modify epileptogenesis in humans. Biomarker analysis will be performed by a multidisciplinary, systematic approach in three clinical settings:
1/ prospective study of epilepsy development in infants with TSC, including analysis of clinical, neuroimaging, and molecular, blood-derived biomarkers at predefined time points: before the onset of seizures, at the onset of epileptiform discharges on EEG, at seizure onset and at the age of 24 months
2/ prospective study of blood-based biomarkers in infants with TSC treated with antiepileptic drugs prior to seizure onset in comparison to children treated only after clinical seizures appearance.
3/ analysis of biomarkers of epileptogenesis and drug-resistant epilepsy in brain specimens obtained from TSC patients who have had epilepsy surgery and TSC autopsy cases.
EPISTOP will be carried out by a consortium of 14 partners from 9 countries, including 2 SMEs.
Fields of science
Call for proposal
FP7-HEALTH-2013-INNOVATION-1
See other projects for this call
Funding Scheme
CP-IP - Large-scale integrating projectCoordinator
04730 Warszawa
Poland
See on map
Participants (16)
00133 Roma
See on map
75654 Paris
See on map
1050 Bruxelles / Brussel
See on map
150 06 Praha 5
See on map
10117 Berlin
See on map
3584 CX Utrecht
See on map
1105AZ Amsterdam
See on map
3000 Leuven
See on map
1090 Wien
See on map
02109 WARSZAWA
See on map
02115 BOSTON MA
See on map
12489 BERLIN
See on map
2333 BZ LEIDEN
See on map
00185 ROMA
See on map
QLD 4101 Brisbane
See on map
2333 BZ Leiden
See on map